results the ace inhibitory activities of hydroalcoholic extracts were as follows; m. vulgare > n. jatamansi > p. ferulacea. the least ic50 value was related to the hydroalcoholic extract of m. vulgare (0.791 mg/ml). the ic50 values of n. jatamansi and p. ferulacea were 2.147 and 4.057 mg/ml, respectively. conclusions the results supported the traditional antihypertensive use of these plants, es...

BACKGROUND The effect on cardiovascular outcomes of withholding angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in chronic users before noncardiac surgery is unknown. METHODS In this international prospective cohort study, the authors analyzed data from 14,687 patients (including 4,802 angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker users) ...

there are controversial reports about the effect of captopril on pain modulation. also while captopril may potentiate morphine analgesia, enalapril has not such an effect and interaction of morphine with angiotensin ii receptor antagonists and other angiotensin converting enzyme inhibitors has not been studied yet. therefore, this study was designed to assess the effect of captopril, lisinopril...

Angiotensin-converting enzyme-2 (ACE-2) is an essential element in the renin-angiotensin RAS system and plays a key role coronavirus entrance to human body attachment cell. Variation ACE-2 may increase capability of binding with tissues lead variation disease severity among patients. For this reason, study aimed take some SNPs different COVID-19 patient cases show possible Angiotensin-Convertin...

The angiotensin-converting enzyme from rabbit lung was purified to a homogeneous protein. The molecular weight of the enzyme or its subunits in sodium dodecyl sulfate-polyacrylamide gel electrophoresis was established as 180,000. Converting enzyme contained about 8% (w/w) hexoses (based on glucose). The K,,, values for the hydrolysis of angiotensin I and [desAspllangiotensin I by the purified e...

Serum angiotensin-converting enzyme activities were measured in 41 type 1 diabetics (16.4 +/- 4.0 U/ml), in 40 type 2 diabetics (15.0 +/- 5.2 U/ml) and in 52 controls (13.0 +/- 2.7 U/ml, mean +/- SD). Twenty six (32%) of 81 patients presented with serum angiotensin-converting enzyme activities above the normal range. No relation between serum angiotensin-converting enzyme activities and the pre...

The angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis represents a promising target for inducing stroke neuroprotection. Here, we explored stroke-induced changes in expression and activity of endogenous angiotensin-converting enzyme 2 and other system components in Sprague-Dawley rats. To evaluate the clinical feasibility of treatments that target this axis and that may act in synergy ...

Background and aims: Diabetic nephropathy (DN) is the most common cause of end-stage renal failure which could increase the risk of cardiovascular disease and morbidity and mortality in patients. The aim of this study was to investigate new modalities for treatment of diabetic nephropathy. Methods:This study was a mini-review research to investigate drugs that are used for DN treatment. Resul...

Increased activity of the renin-angiotensin system has been implicated in decreased, long-term survival of renal allografts. Recent studies suggest that a deletion variant of the angiotensin-converting enzyme, associated with increased humoral and tissue activity of this enzyme, is a risk factor for the development of diabetic nephropathy and the progression of IgA nephropathy. To determine whe...